Related Experiment Video
Updated: Aug 14, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
[Cardiac risks of hypokalemia and hypomagnesemia]
1Klinik und Poliklinik für Innere Medizin II, Universität Regensburg. bernhard.kraemer@klinik.uni-regensburg.de
Insights
Low-dose diuretics, unlike high doses, reduce risks of hypokalemia and hypomagnesemia. Modern treatments combining ACE inhibitors and spironolactone further mitigate these electrolyte imbalances, improving patient survival and cardiovascular outcomes.
Area of Science:
- Cardiology
- Pharmacology
Abstract:
During treatment with low to moderate doses of thiazides or loop diuretics, hypokalemia is dose-dependently demonstrated in 2-11% of patients. Additional hypomagnesemia is present in about 40% of hypokalemic patients. High doses of diuretics were routinely used in the past for treatment of hypertension or heartfailure, causing ventricular arrhythmias and sudden cardiac death. Low-dose thiazides +/- potassium-sparing diuretic are not associated with these severe adverse effects, but improve in contrast (to high-dose diuretics) survival and cardiovascular morbidity in hypertensive patients. Higher doses of diuretics often necessary in the treatment of patients with severe heart failure are today no longer regularly associated with hypokalemia/hypomagnesemia because of the concomitant treatment with an ACE inhibitor and low-doses of spironolactone.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Cardiac Catheterization I: Pre-Procedure Overview
Chronic Kidney Disease II: Clinical Manifestations

